Does PEP Compensate the Reduction of Tidal Volume During One Lung Ventilation? (REVOLU)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
During general anesthesia, airway closure and the formation of atelectasis impair oxygenation. During one-lung ventilation, large tidal volumes are used to resume atelectasis with a risk of regional over distension and Ventilator-Induced Lung Injury (VILI). The reduction in TV should reduce the occurrence of VILI but lead to a consistent alveolar derecruitment. This harmful effect may be counteracted by PEP. We, therefore, study the impact on oxygenation, of increasing PEP during OLV, in order to maintain alveolar recruitment when TV is reduced.
| Condition | Intervention |
|---|---|
|
Lung Neoplasms Pulmonary Disease |
Procedure: One-Lung ventilation Procedure: One-Llung ventilation |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Crossover Assignment Masking: Single Blind (Subject) Primary Purpose: Supportive Care |
| Official Title: | Lowering VT and Increasing PEP During One-Lung Ventilation (OLV), Impact on Oxygenation |
- PaO2/FiO2 after 10 minutes of each strategy [ Time Frame: 15 minutes after selective intubation and 10 minutes after the beginning of each ventilation type. ] [ Designated as safety issue: No ]
- Occurrence of intrinsic PEP. [ Time Frame: Peroperative period ] [ Designated as safety issue: Yes ]
- Haemodynamic side effects: decrease of more than 20% of the arterial systolic blood pressure [ Time Frame: peroperative period ] [ Designated as safety issue: Yes ]
| Enrollment: | 88 |
| Study Start Date: | November 2007 |
| Study Completion Date: | January 2009 |
| Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| 1 |
Procedure: One-Lung ventilation
Low Vt, High PEP
|
| 2 |
Procedure: One-Llung ventilation
High Vt, low PEP
|
Detailed Description:
Approval Status: Approved Approval Number: 2007-06 Board Name: CPP Sud Ouest et Outre-Mer 3 Board Affiliation: French Ministry of Health (DGS) Phone: Email: cpp.soom3@orange.fr No France: Afssaps - French Health Products Safety Agency
During general anesthesia, airway closure and the formation of atelectasis impair oxygenation. During one-lung ventilation, large tidal volumes are used to resume atelectasis with a risk of regional over distension and Ventilator-Induced Lung Injury (VILI). The reduction in TV should reduce the occurrence of VILI but lead to a consistent alveolar derecruitment. This harmful effect may be counteracted by PEP. We, therefore, study the impact on oxygenation, of increasing PEP during OLV, in order to maintain alveolar recruitment when TV is reduced.
A recent study reported that mechanical ventilation with large intraoperative TV is associated with an increased risk of post-pneumonectomy respiratory failure. Indeed, large TV during OLV may lead to Ventilator-Induced Lung Injury (VILI) with the creation of alveolar stretch injury and the development of permeability pulmonary edema. The reduction in TV should reduce the occurrence of VILI but lead to a consistent alveolar derecruitment. This harmful effect may be counteracted by PEP. Therefore, once TV is reduced, PEP may play a key role in minimizing lung collapse and preventing lung units from repeated opening and collapse phases. Such "protective" ventilatory strategy may be proposed if it does not lead to hypoxemia during exclusion. We, therefore, study the impact on oxygenation, of increasing PEP in order to maintain recruitment, keeping Pplat constant when TV is reduced. We will compare, in each patient without severe pulmonary obstructive disease (FEV1 and FEV1 /CV > 70%), two strategies of ventilation with two different levels of TV and PEP, but keeping the same Pplat :
After induction of anesthesia, fiberoptic bronchoscopy confirms the correct position of the tube. Anesthesia is maintained with sevoflurane with a BIS® objective between 45 and 55. Boluses of sufentanyl and cisatracurium are done when clinically necessary. Patients are ventilated in VCV with a ZEUS® respiratory device (Dragger, Germany). Before incision, patients are switched to one-lung ventilation in the lateral position. The tidal volume (TV) is 8 ml/kg of ideal body weight, with a maximal plateau pressure limited to 32 cm H2O. The ventilatory frequency is adjusted in order to maintain end tidal concentrations of carbon dioxide (PetCO2) between 30 to 35 mmHg. 5 cmH2O of positive end expiratory pressure (PEP) is used, and the inspired oxygen fraction is adjusted in order to maintain the pulse oxymetry above 95%. During OLV, if SpO2 decreases to less than 90% with 100% of inspired oxygen fraction, surgery is temporarily stopped to resume two lungs ventilation until SpO2 recover at least 95%. If necessary, a continuous positive airway pressure (CPAP) with 5 cm H2O of oxygen is maintained to provide the non dependent lung. Datas are recorded when the chest is opened. The alveolar pressures and the inspiratory and expiratory flow time curves are monitored. After a period of 15 min, the two strategies are compared in a random order :
- TV of 8 ml/kg of ideal body weight and a PEP of 5 cmH2O during 10 minutes
- TV of 5 ml/kg and a PEP level in order to keep the same plateau pressure during 10 minutes.
Arterial blood gases are measured after 10 minutes using each strategy and before any vessels are ligated. The occurrence of PEPi is detected on the expiratory flow time curve.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age> 18 years
- Open-chest thoracotomy for pulmonary resection
- oral consent
Exclusion Criteria:
- Severe obstructive disease (FEV1 or FEV1 /CV < 70%)
- Patient who don't tolerate a one-lung ventilation
Contacts and Locations| France | |
| Département d'Anesthésie-Réanimation II, Groupe Hospitalier Sud, CHU de Bordeaux | |
| Pessac, France, 33604 | |
| Principal Investigator: | Hadrien ROZE, Dr | University Hospital, Bordeaux |
| Study Chair: | Paul PEREZ, Dr | University Hospital (USMR), Bordeaux |
More Information
Publications:
| Responsible Party: | Julie Boussuge, University Hospital, Bordeaux |
| ClinicalTrials.gov Identifier: | NCT00534690 History of Changes |
| Other Study ID Numbers: | CHUBX 2007/06 |
| Study First Received: | September 24, 2007 |
| Last Updated: | January 20, 2010 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Keywords provided by University Hospital, Bordeaux:
|
Pulmonary disease Intubation, Intratracheal Positive-pressure ventilation |
Additional relevant MeSH terms:
|
Neoplasms Lung Diseases Respiration Disorders Lung Neoplasms |
Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site |
ClinicalTrials.gov processed this record on May 19, 2013